These results are consistent with previous functional studies of GNAI1 and GNAI2 in other cancers [20, 63], but our study is the first to experimentally validate the functional roles of these genes in COAD, supporting their candidacy as therapeutic targets. This evidence concerns the gene GNAI1 and cancer.